Longistylin C exhibits potential in pharmaceutical research due to its structural properties that suggest anti-inflammatory and cytotoxic activities. It has been investigated for its ability to interact with cellular pathways involved in cancer progression, showing promise as a lead compound in anticancer drug development. Additionally, its natural origin and bioactivity make it a candidate for use in studying plant-based defense mechanisms and developing novel therapeutic agents derived from natural products.